Raymond James Financial Services Advisors, Inc. Novartis Ag Transaction History

Raymond James Financial Services Advisors, Inc.

  • $73.5 Billion
  • Q3 2024

A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 330,063 shares of NVS stock, worth $34 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
330,063
Previous 354,449 6.88%
Holding current value
$34 Million
Previous $37.7 Million 0.61%
% of portfolio
0.05%
Previous 0.05%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024
SELL
$106.13 - $120.89 $2.59 Million - $2.95 Million
-24,386 Reduced 6.88%
330,063 $38 Million
Q2 2024

Jul 19, 2024
BUY
$92.57 - $107.37 $1.53 Million - $1.77 Million
16,492 Added 4.88%
354,449 $37.7 Million
Q1 2024

Apr 22, 2024
SELL
$95.27 - $108.47 $881,914 - $1 Million
-9,257 Reduced 2.67%
337,957 $32.7 Million
Q4 2023

Jan 16, 2024
SELL
$92.27 - $101.54 $19,653 - $21,628
-213 Reduced 0.06%
347,214 $35.1 Million
Q3 2023

Oct 24, 2023
BUY
$94.73 - $105.13 $615,745 - $683,345
6,500 Added 1.91%
347,427 $35.4 Million
Q2 2023

Jul 25, 2023
BUY
$92.52 - $104.91 $838,231 - $950,484
9,060 Added 2.73%
340,927 $34.4 Million
Q1 2023

Apr 14, 2023
SELL
$80.03 - $92.81 $1.94 Million - $2.25 Million
-24,246 Reduced 6.81%
331,867 $30.5 Million
Q4 2022

Feb 08, 2023
SELL
$75.55 - $92.52 $2.46 Million - $3.01 Million
-32,526 Reduced 8.37%
356,113 $32.3 Million
Q3 2022

Oct 25, 2022
BUY
$74.61 - $87.26 $551,666 - $645,200
7,394 Added 1.94%
388,639 $29.5 Million
Q2 2022

Aug 12, 2022
BUY
$80.52 - $93.75 $854,719 - $995,156
10,615 Added 2.86%
381,245 $32.2 Million
Q1 2022

May 11, 2022
BUY
$80.11 - $90.62 $5.63 Million - $6.37 Million
70,325 Added 23.42%
370,630 $32.5 Million
Q4 2021

Feb 08, 2022
BUY
$79.7 - $88.13 $544,510 - $602,104
6,832 Added 2.33%
300,305 $26.3 Million
Q3 2021

Nov 02, 2021
BUY
$81.78 - $95.14 $1.61 Million - $1.87 Million
19,635 Added 7.17%
293,473 $24 Million
Q2 2021

Aug 11, 2021
BUY
$85.24 - $94.15 $1.4 Million - $1.54 Million
16,385 Added 6.36%
273,838 $25 Million
Q1 2021

May 14, 2021
BUY
$83.5 - $98.47 $1.29 Million - $1.52 Million
15,479 Added 6.4%
257,453 $22 Million
Q4 2020

Feb 12, 2021
SELL
$78.07 - $94.43 $139,354 - $168,557
-1,785 Reduced 0.73%
241,974 $22.8 Million
Q3 2020

Nov 04, 2020
BUY
$82.14 - $91.0 $853,106 - $945,126
10,386 Added 4.45%
243,759 $21.2 Million
Q2 2020

Jul 17, 2020
SELL
$80.93 - $91.1 $157,813 - $177,645
-1,950 Reduced 0.83%
233,373 $20.4 Million
Q1 2020

Apr 21, 2020
BUY
$70.67 - $99.01 $2.11 Million - $2.96 Million
29,849 Added 14.53%
235,323 $19.4 Million
Q4 2019

Feb 12, 2020
BUY
$84.35 - $95.37 $1.95 Million - $2.2 Million
23,079 Added 12.65%
205,474 $19.5 Million
Q3 2019

Nov 07, 2019
SELL
$85.54 - $94.26 $687,313 - $757,379
-8,035 Reduced 4.22%
182,395 $15.9 Million
Q2 2019

Aug 06, 2019
BUY
$75.4 - $92.8 $1.45 Million - $1.78 Million
19,184 Added 11.2%
190,430 $17.4 Million
Q1 2019

May 06, 2019
BUY
$75.32 - $86.15 $2.5 Million - $2.86 Million
33,241 Added 24.09%
171,246 $16.5 Million
Q4 2018

Feb 11, 2019
BUY
$73.66 - $82.02 $607,326 - $676,254
8,245 Added 6.35%
138,005 $11.8 Million
Q3 2018

Nov 14, 2018
BUY
$66.94 - $77.43 $74,102 - $85,715
1,107 Added 0.86%
129,760 $11.2 Million
Q2 2018

Jul 30, 2018
BUY
$64.91 - $73.36 $30,507 - $34,479
470 Added 0.37%
128,653 $9.72 Million
Q1 2018

Apr 16, 2018
BUY
$70.39 - $84.15 $899,443 - $1.08 Million
12,778 Added 11.07%
128,183 $10.4 Million
Q4 2017

Feb 09, 2018
SELL
$72.33 - $77.64 $111,460 - $119,643
-1,541 Reduced 1.32%
115,405 $9.69 Million
Q3 2017

Oct 26, 2017
BUY
$74.14 - $77.27 $1,853 - $1,931
25 Added 0.02%
116,946 $10 Million
Q2 2017

Aug 15, 2017
BUY
N/A
116,921
116,921 $9.76 Million

Others Institutions Holding NVS

# of Institutions
1,434
Shares Held
133M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $222B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Raymond James Financial Services Advisors, Inc. Portfolio

Follow Raymond James Financial Services Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email